Lates News

Taking advantage of the rebound in stock prices, Hillhouse Capital has reduced its holdings of BeiGene's US stocks several times this year. On the evening of May 14, BeiGene announced that Hillhouse Capital's platform had once again reduced its holdings of the company's stocks. According to BeiGene, this time Hillhouse Capital reduced its holdings of the company's US stocks. Based on the lowest price of $230.23 per share on May 9, the funds cashed out by Hillhouse Capital from BeiGene's shares can reach $3.68 billion. It was noted that after selling off BeiGene's shares this time, Hillhouse Capital turned to subscribe to the Hong Kong IPO of Hutchison Medicine (600276.SH). (First Financial News)